EUVIMEDEUVIMED entdecken
Multizentrische Studie

Impact of COVID-19 on patients undergoing scheduled procedures for chronic venous disease

Ethan Moore iD, Max V Wohlauer, James Dorosh, Mahmood Kabeil, Rafael D Malgor iD, Leigh A O'Banion, Gabriel Lopez-Pena, Riley Gillette, Kathryn Colborn, Robert F Cuff, Leah Lucero, Amna Ali und 24 weitere

Vascular · 2025

DOI: 10.1177/17085381241240679 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Vascular, 2025. Verfasst von Ethan Moore und 35 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Colorado School of Medicine, Aurora, CO, USA. Hauptthemen laut MEDLINE: COVID-19, Vascular Surgical Procedures, Elective Surgical Procedures, Time-to-Treatment. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The COVID-19 pandemic has drastically altered the medical landscape. Various strategies have been employed to preserve hospital beds, personal protective equipment, and other resources to accommodate the surges of COVID-19 positive patients, hospital overcapacities, and staffing shortages. This has had a dramatic effect on vascular surgical practice. The objective of this study is to analyze the impact of the COVID-19 pandemic on surgical delays and adverse outcomes for patients with chronic venous disease scheduled to undergo elective operations.

Methods

The Vascular Surgery COVID-19 Collaborative (VASCC) was founded in March 2020 to evaluate the outcomes of patients with vascular disease whose operations were delayed. Modules were developed by vascular surgeon working groups and tested before implementation. A data analysis of outcomes of patients with chronic venous disease whose surgeries were postponed during the COVID-19 pandemic from March 2020 through February 2021 was performed for this study.

Results

A total of 150 patients from 12 institutions in the United States were included in the study. Indications for venous intervention were: 85.3% varicose veins, 10.7% varicose veins with venous ulceration, and 4.0% lipodermatosclerosis. One hundred two surgeries had successfully been completed at the time of data entry. The average length of the delay was 91 days, with a median of 78 days. Delays for venous ulceration procedures ranged from 38 to 208 days. No patients required an emergent intervention due to their venous disease, and no patients experienced major adverse events following their delayed surgeries.

Conclusions

Interventions may be safely delayed for patients with venous disease requiring elective surgical intervention during the COVID-19 pandemic. This finding supports the American College of Surgeons’ recommendations for the management of elective vascular surgical procedures. Office-based labs may be safe locations for continued treatment when resources are limited. Although the interventions can be safely postponed, the negative impact on quality of life warrants further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Vascular Surgical ProceduresElective Surgical ProceduresTime-to-TreatmentVaricose VeinsHumansChronic DiseaseFemaleMaleMiddle AgedAgedUnited StatesTreatment OutcomeTime FactorsAdult

Stichwörter der Autor:innen

COVID-19delayedoffice based laboratorysurgeryvenous

Autor:innen und Institutionen

  • Department of Surgery, University of Colorado School of Medicine, Aurora, CO, USA.
  • Deparment of Surgery, McLaren Greater Lansing at Michigan State University, East Lansing, MI, USA.
  • Department of Surgery, University of California San Francisco Fresno, Fresno, CA, USA.
  • Department of Surgery, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Department of Surgery, Spectrum Health/Michigan State University, Grand Rapids, MI, USA.
  • Department of Surgery, RWJ/Barnabas Health, Toms River, NJ, USA.

ORCID-Profile: Ethan Moore, Rafael D Malgor

Zitieren

APA

Moore, E., Wohlauer, M. V., Dorosh, J., Kabeil, M., Malgor, R. D., O'Banion, L. A., Lopez-Pena, G., Gillette, R., Colborn, K., Cuff, R. F., Lucero, L., Ali, A., Koleilat, I., Batarseh, P., Talathi, S., Rivera, A., Humphries, M. D., Ly, K., Harroun, N., …, & Lin, J. C. (2025). Impact of COVID-19 on patients undergoing scheduled procedures for chronic venous disease. Vascular. https://doi.org/10.1177/17085381241240679

Vancouver

Moore E, Wohlauer MV, Dorosh J, Kabeil M, Malgor RD, O'Banion LA, et al. Impact of COVID-19 on patients undergoing scheduled procedures for chronic venous disease. Vascular. 2025. doi:10.1177/17085381241240679

BibTeX
@article{Moore2025,
  author = {Moore, Ethan and Wohlauer, Max V and Dorosh, James and Kabeil, Mahmood and Malgor, Rafael D and O'Banion, Leigh A and Lopez-Pena, Gabriel and Gillette, Riley and Colborn, Kathryn and Cuff, Robert F and Lucero, Leah and Ali, Amna and Koleilat, Issam and Batarseh, Paola and Talathi, Sonia and Rivera, Aksim and Humphries, Misty D and Ly, Kevin and Harroun, Nikolai and Smith, Brigitte K and Darelli-Anderson, Anna M and Choudhry, Asad and Hammond, Eric and Costanza, Michael and Khetarpaul, Vipul and Cosentino, Ashley and Watson, Jacob and Afifi, Rana and Mouawad, Nicolas J and Tan, Tze-Woei and Sharafuddin, Mel and Quevedo, Judith P and Nkansah, Reggie and Shibale, Palcah and Shalhub, Sherene and Lin, Judith C},
  title = {Impact of COVID-19 on patients undergoing scheduled procedures for chronic venous disease},
  journal = {Vascular},
  year = {2025},
  doi = {10.1177/17085381241240679}
}
Kostenlos starten →